- Recce Pharmaceuticals (RCE) has begun the process to dual list on the Frankfurt Stock Exchange (FSE)
- The company has appointed Deutsche Gesellschaft Für Wertpapieranalyse (DGWA) as its investor and corporate relations advisor in Europe
- DGWA will engage prospective investors and drive awareness of Recce's productsDual listing on the FSE will give Recce exposure to multiple retail and institutional investors in the European Union
- The company will keep the market updated as the listing progresses Shares in Recce are steady on the market and are trading at $1.05 per share
Read the full article on The Market Herald here.
- Forums
- ASX - By Stock
- RCE
- Recce Pharmaceuticals (ASX:RCE) to dual list on FSE
RCE
recce pharmaceuticals ltd
Add to My Watchlist
1.69%
!
29.0¢

Recce Pharmaceuticals (ASX:RCE) to dual list on FSE
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $83.62M |
Open | High | Low | Value | Volume |
29.0¢ | 30.0¢ | 28.5¢ | $37.25K | 127.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 161128 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 9666 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 161128 | 0.285 |
10 | 343798 | 0.280 |
4 | 37019 | 0.275 |
4 | 24814 | 0.270 |
1 | 5000 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 9666 | 1 |
0.330 | 114230 | 1 |
0.350 | 31739 | 3 |
0.375 | 8002 | 1 |
0.380 | 6820 | 2 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |